Viridian Therapeutics, Inc.\DE (VRDN) Return on Equity [ROE] (2014 - 2026)
Viridian Therapeutics, Inc.\DE's Return on Equity [ROE] came in at -60.26% for Q2 2026, up 1.11 percentage points from -61.37% a year earlier but down 6.40 percentage points from the prior quarter.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Return on Equity [ROE] (2014 - 2026) Analysis & Trends
For FY2025, Viridian Therapeutics, Inc.\DE's Return on Equity [ROE] was -48.92%, down 0.50 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of +114.40 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -48.42% in FY2024 (+8.33 pp), -56.75% in FY2023 (-12.18 pp), -44.57% in FY2022 (+7.04 pp) and -51.61% in FY2021 (+111.71 pp).
- The five-year range for quarterly Return on Equity [ROE] is -93.11% (Q3 2021) to -32.30% (Q4 2022).
- Year-over-year, Return on Equity [ROE] increased in three of the last eight quarters, with an average year-over-year change of -0.98 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q4 2021 (a gain of 116.69 percentage points), and the weakest in Q4 2023 (a drop of 33.17 percentage points).
- Business Quant data shows VRDN's Return on Equity [ROE] at -53.86% (Q1 2026), -55.65% (Q4 2025) and -59.35% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 4.97% |
| 10 | Viridian Therapeutics, Inc.\DE | 2.15 Bn | 2.15 Bn | - | -60.26% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -60.26% |
| Mar 31, 2026 | -53.86% |
| Dec 31, 2025 | -55.65% |
| Sep 30, 2025 | -59.35% |
| Jun 30, 2025 | -61.37% |
| Mar 31, 2025 | -48.25% |
| Dec 31, 2024 | -39.08% |
| Sep 30, 2024 | -41.51% |
| Jun 30, 2024 | -40.99% |
| Mar 31, 2024 | -42.54% |
| Dec 31, 2023 | -65.47% |
| Sep 30, 2023 | -72.29% |
| Jun 30, 2023 | -59.39% |
| Mar 31, 2023 | -46.23% |
| Dec 31, 2022 | -32.30% |
| Sep 30, 2022 | -41.04% |
| Jun 30, 2022 | -63.64% |
| Mar 31, 2022 | -48.90% |
| Dec 31, 2021 | -40.51% |
| Sep 30, 2021 | -93.11% |
API Access
Viridian Therapeutics, Inc.\DE Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();